1763 — China Isotope & Radiation Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for China Isotope & Radiation, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,144	6,154	6,635	7,575	7,188
Cost of Revenue
Gross Profit	3,242	3,518	3,482	3,683	3,622
Selling / General / Administrative Expenses
Research And Development
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,366	5,240	5,693	6,488	6,129
Operating Profit	778	914	942	1,086	1,059
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	803	921	922	1,045	1,004
Provision for Income Taxes
Net Income After Taxes	673	755	776	880	665
Minority Interest
Net Income Before Extraordinary Items
Net Income	336	392	371	407	327
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	336	392	371	407	327
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.04	1.17	0.674	1.32	1.02
Dividends per Share